| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥436.1B | ¥423.8B | +2.9% |
| Operating Income | ¥19.2B | ¥20.3B | -5.2% |
| Ordinary Income | ¥20.4B | ¥20.9B | -2.7% |
| Net Income | ¥15.0B | ¥13.0B | +15.8% |
| ROE | 8.5% | 7.7% | - |
FY2025 Q3 results show revenue of 436.1 billion yen (YoY +2.9%), operating income of 19.2 billion yen (YoY -5.2%), ordinary income of 20.4 billion yen (YoY -2.7%), and net income of 15.0 billion yen (YoY +15.8%). The company achieved top-line growth but experienced contraction in operating profitability, primarily driven by increased costs and general administrative expenses. Despite the operating income decline, net income improved significantly due to extraordinary gains and favorable non-operating items. The divergence between operating performance and bottom-line results highlights the importance of distinguishing recurring from non-recurring profit drivers in evaluating underlying business health.
Revenue increased 12.3 billion yen year-over-year to 436.1 billion yen, representing growth of 2.9%. The Nursing Care Service segment, which constitutes the core business, generated external sales of 432.4 billion yen, up from 415.6 billion yen in the prior year period, contributing approximately 99.2% of total revenue. The Other segment, comprising outsourcing services and care robot planning and sales, recorded external sales of 3.7 billion yen, down from 8.1 billion yen, reflecting a strategic shift away from certain ancillary businesses such as nursing care insurance claim ASP system sales.
Operating income decreased 1.1 billion yen to 19.2 billion yen despite revenue growth, indicating margin compression. Cost of sales increased from 372.4 billion yen to 380.8 billion yen, representing 87.3% of revenue compared to 87.9% in the prior year, showing modest gross margin improvement from 12.1% to 12.7%. However, selling, general and administrative expenses absorbed these gains and expanded further, rising from 360.5 billion yen equivalent levels (implied) to higher levels, with corporate-level unallocated expenses increasing from 18.7 billion yen to 22.6 billion yen according to segment reconciliation notes. The Nursing Care Service segment's operating profit improved from 13.2 billion yen to 16.1 billion yen at the segment level, but consolidated operating income declined due to 389 million yen increase in corporate overhead.
The gap between operating income (19.2 billion yen) and ordinary income (20.4 billion yen) reflects net non-operating gains of approximately 1.2 billion yen. Net income of 15.0 billion yen exceeded ordinary income adjusted for extraordinary items, benefiting from special gains totaling approximately 2.5 billion yen, which included proceeds from subsidiary stock sales and fixed asset disposals. These non-recurring factors contributed materially to the 15.8% year-over-year increase in net income, contrasting with the operating income decline.
This represents a revenue up, profit down pattern at the operating level, transitioning to revenue up, profit up at the net income level due to extraordinary items. The core operating challenge centers on controlling the rate of expense growth relative to revenue expansion, particularly corporate-level costs that offset segment-level profitability improvements.
The Nursing Care Service segment represents the core business, generating 432.4 billion yen in external revenue (99.2% of consolidated sales) and 16.1 billion yen in segment operating income. Revenue increased 4.0% year-over-year from 415.6 billion yen, while segment operating profit improved 22.2% from 13.2 billion yen. The segment operating margin expanded to 3.7% from 3.2%, indicating improving operational efficiency at the business unit level. The Other segment contributed 3.7 billion yen in external revenue with segment operating income of 233 million yen, down substantially from prior year revenue of 8.1 billion yen and segment profit of 952 million yen. This segment now represents less than 1% of total revenue and has materially contracted, consistent with management's apparent focus on the core nursing care business. The margin differential is notable, with the Other segment generating a 6.3% operating margin (233 million yen / 3.7 billion yen) compared to 3.7% for Nursing Care Services, though the Other segment's absolute contribution has diminished significantly. Corporate unallocated expenses of 22.6 billion yen represent a 20.8% increase from 18.7 billion yen in the prior year, serving as the primary drag on consolidated operating profitability despite segment-level improvements.
[Profitability] ROE of 8.5% compares to the company's historical trend and represents return on equity based on net income of 15.0 billion yen against total equity of 176.6 billion yen. Operating margin of 4.4% declined from 4.8% in the prior year (20.3 billion yen / 423.8 billion yen), reflecting the operating profit pressure described above. Net profit margin improved to 3.4% from 3.1% year-over-year, primarily driven by extraordinary gains rather than operational efficiency. Gross profit margin expanded modestly to 12.7% from 12.1%, providing limited cushion given the labor-intensive nature of nursing care services. [Cash Quality] Cash and deposits totaled 72.8 billion yen, providing coverage of 1.11 times against short-term liabilities of 65.6 billion yen. Operating working capital shows accounts receivable of 84.6 billion yen, representing days sales outstanding of approximately 71 days, which suggests extended collection cycles typical of healthcare reimbursement structures. [Investment Efficiency] Asset turnover of 1.49 times (436.1 billion yen revenue / 293.1 billion yen average total assets) indicates moderate asset utilization. Return on assets of 5.1% (15.0 billion yen / 293.1 billion yen) reflects the combination of asset-intensive operations and modest net margins. [Financial Health] Equity ratio stands at 60.3% (176.6 billion yen equity / 293.1 billion yen total assets), up from 55.3% in the prior year, indicating strengthened financial stability. Current ratio of 250.2% and quick ratio of 249.0% demonstrate strong short-term liquidity. Long-term debt decreased dramatically from 10.5 billion yen to 0.3 billion yen, representing a 97.6% reduction that eliminates most interest-bearing debt. Debt-to-equity ratio of 0.66 includes all liabilities and reflects conservative capital structure with minimal leverage risk.
Cash and deposits increased 3.1 billion yen year-over-year to 72.8 billion yen, reflecting cash accumulation despite operating margin pressure. The balance sheet shows net working capital expansion through accounts receivable growth of 6.4 billion yen to 84.6 billion yen, indicating that revenue growth has required incremental working capital investment with extended payment cycles. Accounts payable increased 1.7 billion yen to 18.8 billion yen, providing partial working capital relief through supplier credit extension. The 10.2 billion yen reduction in long-term borrowings from 10.5 billion yen to 0.3 billion yen represents significant debt repayment that consumed cash resources but eliminated ongoing interest expense and financial leverage risk. Short-term borrowings remain at zero, maintaining the company's conservative approach to debt financing. Property, plant and equipment increased modestly from 52.7 billion yen to 54.5 billion yen, suggesting measured capital investment of approximately 1.8 billion yen at minimum (before depreciation), consistent with facility maintenance and selective expansion in the nursing care service network. The 2.0 billion yen increase in goodwill from 3.8 billion yen to 5.8 billion yen reflects the acquisition of Ai Life Service Corporation, representing approximately 252 million yen in new goodwill from this transaction. Total assets decreased 11.7 billion yen from 304.8 billion yen to 293.1 billion yen, indicating asset rationalization that may have generated proceeds contributing to debt reduction. Cash coverage of short-term liabilities of 1.11 times provides adequate liquidity buffer for operational needs and confirms financial flexibility despite the working capital intensity of the business model.
Ordinary income of 20.4 billion yen versus operating income of 19.2 billion yen indicates net non-operating contributions of approximately 1.2 billion yen, representing 0.3% of revenue. Non-operating income components include interest and dividend income along with equity method gains from affiliated companies. The gap between ordinary income (20.4 billion yen) and net income before tax (estimated at 22.9 billion yen based on tax burden calculations) reveals extraordinary gains of approximately 2.5 billion yen, constituting roughly 0.6% of revenue and representing material one-time benefits. These extraordinary items include subsidiary stock sale gains and fixed asset disposal proceeds that are non-recurring in nature. The 15.8% growth in net income compared to the 5.2% decline in operating income demonstrates significant dependency on below-the-line items for bottom-line performance. The effective tax rate of approximately 34.4% appears within normal corporate tax ranges. Working capital expansion evidenced by accounts receivable growth exceeding revenue growth (7.6% versus 2.9%) suggests some earnings are tied up in receivables rather than converted to cash, which represents a caution flag for earnings quality from a cash realization perspective. The structural challenge of low gross margins at 12.7% and operating margins at 4.4% indicates that core business profitability remains constrained, with earnings quality dependent on tight cost control rather than strong pricing power or operational leverage. The non-recurring nature of extraordinary gains supporting current year net income means that sustainable earnings power is better reflected by the operating income level, which remains under pressure.
Full-year guidance calls for revenue of 585.9 billion yen, operating income of 20.6 billion yen, ordinary income of 20.3 billion yen, and net income of 13.4 billion yen. Q3 year-to-date progress rates show revenue achievement of 74.4% (436.1 billion yen / 585.9 billion yen), operating income achievement of 93.2% (19.2 billion yen / 20.6 billion yen), ordinary income achievement of 100.5% (20.4 billion yen / 20.3 billion yen), and net income achievement of 112.1% (15.0 billion yen / 13.4 billion yen). Against the standard Q3 progress expectation of 75%, revenue tracking is marginally behind at 74.4%, suggesting Q4 revenue of 149.8 billion yen is required, representing a 15.7% sequential increase from the typical quarterly run rate. Operating income progress of 93.2% is significantly ahead of the 75% benchmark, indicating that the company expects Q4 operating income of only 1.4 billion yen, representing a substantial deceleration from the 6.4 billion yen quarterly average achieved through Q3. This implies management anticipates either seasonal headwinds, one-time costs, or strategic investments in Q4 that will materially compress operating margins. Ordinary income progress exceeding 100% and net income progress at 112% suggest the company may be conservatively guiding or that Q3 extraordinary gains are not expected to recur. The full-year guidance implies operating margin compression to 3.5% from the current 4.4% year-to-date level, requiring careful monitoring of Q4 cost dynamics and revenue realization to assess whether guidance proves conservative or requires revision.
The company plans an annual dividend of 30 yen per share for the fiscal year. Based on the current nine-month net income of 15.0 billion yen and basic shares outstanding implied by EPS of 60.89 yen (246.3 million shares), the annualized dividend of 30 yen per share represents a total cash distribution of approximately 7.4 billion yen. Against the full-year guidance net income of 13.4 billion yen, this produces a payout ratio of 55.3%, which is elevated but within sustainable range given the strong balance sheet position. Comparing to the year-to-date net income of 15.0 billion yen on an annualized basis would suggest a payout ratio closer to 49.3%, though this includes non-recurring gains that may not persist. The dividend policy reflects management's commitment to returning capital to shareholders while maintaining financial flexibility. No share buyback program is disclosed in the available materials. With cash and deposits of 72.8 billion yen and minimal interest-bearing debt of 0.3 billion yen, the company maintains substantial financial capacity to support the dividend even if operating cash flow faces pressure from working capital requirements. The total return ratio equals the payout ratio at 55.3% in the absence of buybacks, positioning shareholder returns at a moderate level that balances distribution with reinvestment needs for business expansion and acquisition activity evidenced by the goodwill increase from the Ai Life Service acquisition.
Revenue concentration risk in the Nursing Care Service segment, which represents 99.2% of total sales, creates vulnerability to regulatory changes in nursing care insurance reimbursement rates, labor cost inflation in the care worker market, and demographic shifts affecting demand patterns. Any adverse revision to government reimbursement schedules or tightening of eligibility criteria could materially impact both revenue growth and already-compressed operating margins of 4.4%, with limited diversification to offset segment-specific pressures.
Working capital and cash conversion risk stemming from accounts receivable of 84.6 billion yen with collection cycles of approximately 71 days creates ongoing cash consumption as revenue grows, requiring approximately 2.9 billion yen in incremental receivables for each 10 billion yen revenue increase at current DSO levels. This working capital intensity could constrain cash flow available for dividends, acquisitions, or capital investment if collection cycles extend further or if revenue growth accelerates without corresponding improvements in cash collection efficiency.
Acquisition integration and goodwill impairment risk from the expanding M&A activity, evidenced by goodwill increasing 52.7% to 5.8 billion yen following the Ai Life Service Corporation acquisition, creates exposure to integration execution challenges and potential future impairment charges if acquired operations fail to achieve expected synergies or financial performance. The segment disclosure notes additional goodwill of 252 million yen from this transaction, and any deterioration in acquired business performance could necessitate write-downs that would impact future earnings and equity.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin of 4.4% falls significantly below the IT and Telecom industry median of 8.2% (IQR: 3.7%-17.6%), positioning the company in the lower quartile of operational efficiency. This reflects the labor-intensive, regulated nature of nursing care services with limited pricing power compared to technology-enabled business models. Net profit margin of 3.4% also trails the industry median of 6.0% (IQR: 2.4%-12.3%), though the company remains within the interquartile range. ROE of 8.5% aligns closely with the industry median of 8.3% (IQR: 3.6%-13.1%), indicating that despite lower margins, the company achieves comparable returns through higher asset turnover. ROA of 5.1% exceeds the industry median of 3.9% (IQR: 1.4%-6.9%), suggesting superior asset utilization relative to peers.
Financial Health: Equity ratio of 60.3% exceeds the industry median of 59.2% (IQR: 41.4%-72.1%), positioning the company in the upper half of financial stability. Current ratio of 250.2% substantially exceeds the industry median of 2.13x, reflecting exceptional liquidity management and conservative working capital policies that provide substantial buffer against short-term obligations.
Efficiency: Asset turnover of 1.49x dramatically outperforms the industry median of 0.68x (IQR: 0.49-0.94), demonstrating the company's ability to generate substantially higher revenue per yen of assets employed. This efficiency advantage partially offsets the margin disadvantage relative to higher-margin technology businesses. Receivables turnover of approximately 71 days compares to the industry median of 62 days (IQR: 47-83 days), placing the company in the higher end of collection cycles but within normal range for healthcare-related businesses subject to insurance reimbursement processes.
Growth: Revenue growth of 2.9% lags the industry median of 10.0% (IQR: -1.4%-19.6%), reflecting the mature, regulated nature of the domestic nursing care market compared to higher-growth technology segments. The company's growth profile appears more stable but lower-velocity than typical IT and telecom peers.
Note: Industry classification as IT and Telecom may not fully capture the nursing care services business model, which shares more characteristics with healthcare services in terms of regulatory environment, reimbursement structures, and margin profiles. Comparisons should be interpreted recognizing this classification limitation.
(Industry: IT and Telecom, N=102 companies, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Operating margin compression from 4.8% to 4.4% despite revenue growth of 2.9% signals fundamental challenges in controlling corporate overhead relative to business expansion, with unallocated expenses increasing 20.8% year-over-year substantially exceeding the revenue growth rate. This negative operating leverage represents a critical trend requiring management action on cost structure rationalization, as further margin erosion would threaten dividend sustainability and returns despite the currently strong balance sheet position. The segment-level profit improvement of 22.2% in Nursing Care Services being offset by corporate cost growth suggests potential value creation opportunity if overhead can be controlled.
Net income growth of 15.8% driven substantially by extraordinary gains totaling approximately 2.5 billion yen masks underlying operating performance deterioration, creating a disconnect between reported profitability and sustainable earnings power. The full-year guidance implying Q4 operating income of only 1.4 billion yen versus a 6.4 billion yen quarterly average through Q3 indicates management expects material near-term headwinds, whether seasonal, strategic investment-related, or cost-driven. This guidance profile warrants close monitoring of Q4 results and FY2026 outlook to assess whether current margin pressure represents temporary factors or structural challenges.
Aggressive debt reduction of 10.2 billion yen (97.6% decrease in long-term borrowings) combined with equity ratio expansion to 60.3% and cash holdings of 72.8 billion yen positions the company with exceptional financial flexibility for future capital deployment, whether for acquisitions like the Ai Life Service transaction adding 252 million yen in goodwill, facility expansion in the core nursing care network, or enhanced shareholder returns. This financial capacity provides strategic optionality, though the company must balance capital deployment against working capital needs consuming approximately 2.9 billion yen per 10 billion yen revenue growth at current DSO levels of 71 days.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.